GPC-1 is an important clinical biomarker involved in the process of cancer onset, and it can be used as an important indicator of disease prognoses, such as breast cancer, lung cancer, colorectal cancer, glioma, pancreatic cancer, and esophageal cancer [32]. The gene discussed is GPC1; the disease is pancreatic neoplasm.